Filing Details

Accession Number:
0001213900-21-055660
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-11-01 08:59:35
Reporting Period:
2021-10-28
Accepted Time:
2021-11-01 08:59:35
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1409197 Bespoke Extracts Inc. BSPK Pharmaceutical Preparations (2834) 204743354
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1810668 Danil Pollack C/O Bespoke Extracts, Inc.
323 Sunny Isles Boulevard, Suite 700
Sunny Isles Beach FL 33160
Ceo Yes Yes Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2021-10-28 50,000,000 $0.00 76,000,000 No 4 S Direct
Series C Preferred Stock Disposition 2021-10-28 1 $0.00 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
Footnotes
  1. On October 28, 2021, the Reporting Person entered into a stock purchase agreement with a third party for the sale by the Reporting Person of 50,000,000 shares of common stock and 1 share of Series C Preferred Stock of the Issuer for an aggregate purchase price of $40,000. The closing of the sale is subject to certain conditions set forth in the purchase agreement, including the filing and mailing of a Schedule 14f at least 10 days prior to closing.